SaintMed Public Company Limited

SET:SMD100 Stock Report

Market Cap: ฿951.3m

SaintMed Past Earnings Performance

Past criteria checks 1/6

SaintMed's earnings have been declining at an average annual rate of -7.5%, while the Healthcare industry saw earnings growing at 12.8% annually. Revenues have been growing at an average rate of 2% per year. SaintMed's return on equity is 6.4%, and it has net margins of 6.6%.

Key information

-7.5%

Earnings growth rate

-11.5%

EPS growth rate

Healthcare Industry Growth23.6%
Revenue growth rate2.0%
Return on equity6.4%
Net Margin6.6%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How SaintMed makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

SET:SMD100 Revenue, expenses and earnings (THB Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 24817542310
30 Jun 24748372190
31 Mar 24798612160
31 Dec 23827792070
30 Sep 23750542030
30 Jun 231,0091102050
31 Mar 231,4701682080
31 Dec 222,0102972180
30 Sep 222,2783472220
30 Jun 222,5354692320
31 Mar 222,1744482280
31 Dec 211,6213202170
30 Sep 211,4133032080
30 Jun 218561231920
31 Mar 21704881790
31 Dec 20661781720
30 Sep 20569481710
31 Dec 19619601720
31 Dec 1850635780
31 Dec 17469391370
31 Dec 16565551350

Quality Earnings: SMD100 has a high level of non-cash earnings.

Growing Profit Margin: SMD100's current net profit margins (6.6%) are lower than last year (7.2%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: SMD100's earnings have declined by 7.5% per year over the past 5 years.

Accelerating Growth: SMD100's earnings growth over the past year (1.2%) exceeds its 5-year average (-7.5% per year).

Earnings vs Industry: SMD100 earnings growth over the past year (1.2%) did not outperform the Healthcare industry 8.4%.

Return on Equity

High ROE: SMD100's Return on Equity (6.4%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/28 01:28
End of Day Share Price 2024/12/27 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

SaintMed Public Company Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Nuttawut WongyaowalakGloblex Securities Co. Ltd.